UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)—a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG

Annals of oncology, 2012-10, Vol.23 (10), p.2613-2619

2012

Volltextzugriff (PDF)

One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden

European journal of cancer (1990), 2004-02, Vol.40 (3), p.422-428

2004

Volltextzugriff (PDF)

First‐line treatment of ovarian cancer FIGO stages IIb–IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin

International journal of gynecological cancer, 2003-11, Vol.13 (s2), p.172-177

2003

Volltextzugriff (PDF)

Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

International journal of gynecological cancer, 2006-03, Vol.16 (2), p.507-514

2006

Volltextzugriff (PDF)

Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors

International journal of oncology, 2001-07, Vol.19 (1), p.31

2001

Volltextzugriff (PDF)

Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

International journal of gynecological cancer, 2006-03, Vol.16 (2), p.507-514

2006

Volltextzugriff (PDF)

One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations

European journal of cancer (1990), 2004-02, Vol.40 (3), p.422-428

2004

Volltextzugriff (PDF)

Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: A pilot study of a new digitized scalp-cooling system used in 74 patients

Supportive care in cancer, 2003-06, Vol.11 (6), p.371-377

2003

Volltextzugriff (PDF)

Survival increases for all cancer diagnoses - but inequality persists

Läkartidningen, 2018-05, Vol.115

2018

Volltextzugriff (PDF)

ONE IN 10 OVARIAN CANCER PATIENTS CARRY GERM LINE BRCA1 AND BRCA2 MUTATIONS: RESULTS OF A PROSPECTIVE STUDY IN SOUTHERN SWEDEN

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.22-22

2004

Volltextzugriff (PDF)

NATIONAL BREAST CANCER QUALITY REGISTER AS A POWERFUL TOOL TO IMPROVE TREATMENT

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, Vol.10, p.28

2014

Volltextzugriff (PDF)

Randomized Trial of Single Agent Paclitaxel Given Weekly Versus Every Three Weeks and with Peroral Versus Intravenous Steroid Premedication to Patients with Ovarian Cancer Previously Treated with Platinum

Acta oncologica, 2002, Vol.41 (5), p.418-424

2002

Volltextzugriff (PDF)

TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer

International journal of gynecological cancer, 2002-07, Vol.12 (4), p.362-371

2002

Volltextzugriff (PDF)

First-line treatment of ovarian cancer FIGO stages IIb–IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin

International journal of gynecological cancer, 2003-10, Vol.13 (Suppl 2), p.172-177

2003

Volltextzugriff (PDF)

Open-label, multicenter, phase Ib, dose-escalation study of oral lapatinib (L) in combination with docetaxel (D) and trastuzumab (T) in untreated HER2-overexpressing (HER+) metastatic breast cancer (MBC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.1049-1049

2010

Volltextzugriff (PDF)

Isolation and culture of ovarian tumour cells, cytological and cell survival evaluation

Anticancer research, 1999-11, Vol.19 (6B), p.5069

1999

Volltextzugriff (PDF)

Updated efficacy and safety assessment of first-line therapy with lapatinib, trastuzumab, and paclitaxel in HER2+ metastatic breast cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.1046-1046

2010

Volltextzugriff (PDF)

TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer

International journal of gynecological cancer, 2002-07, Vol.12 (4), p.362-371

2002

Volltextzugriff (PDF)

BRCA1 and BRCA2 mutations in ovarian cancer: Covariation with specific cytogenetic features

International journal of gynecological cancer, 2000-07, Vol.10 (4), p.289-295

2000

Volltextzugriff (PDF)

The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers

Acta oncologica, 2005, Vol.44 (8), p.890-895

2005

Volltextzugriff (PDF)

Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms

Cancer research (Chicago, Ill.), 1993-10, Vol.53 (19), p.4550-4554

1993

Volltextzugriff (PDF)

Progesterone and estradiol stimulate release of epidermal growth factor/transforming growth factor alpha by ovarian tumours in vitro

Anticancer research, 1994-11, Vol.14 (6B), p.2763

1994

Volltextzugriff (PDF)

Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum-taxane : Results from a multicenter phase I/II study

Cancer, 2005-04, Vol.103 (7), p.1388-1396

2005

Volltextzugriff (PDF)

STEROID-HORMONE PRODUCTION AND RECEPTORS IN RELATION TO KI-67, P53, S-PHASE FRACTION AND PLOIDY IN EPITHELIAL OVARIAN-TUMORS

International journal of oncology, 1995-11

1995

Volltextzugriff (PDF)

A Systematic Overview of Radiation Therapy Effects in Cervical Cancer (Cervix Uteri)

Acta oncologica, 2003, Vol.42 (5-6), p.546-556

2003

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(39)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)—a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG

One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden

First‐line treatment of ovarian cancer FIGO stages IIb–IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin

Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors

Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations

Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: A pilot study of a new digitized scalp-cooling system used in 74 patients

Survival increases for all cancer diagnoses - but inequality persists

ONE IN 10 OVARIAN CANCER PATIENTS CARRY GERM LINE BRCA1 AND BRCA2 MUTATIONS: RESULTS OF A PROSPECTIVE STUDY IN SOUTHERN SWEDEN

NATIONAL BREAST CANCER QUALITY REGISTER AS A POWERFUL TOOL TO IMPROVE TREATMENT

Randomized Trial of Single Agent Paclitaxel Given Weekly Versus Every Three Weeks and with Peroral Versus Intravenous Steroid Premedication to Patients with Ovarian Cancer Previously Treated with Platinum

TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer

First-line treatment of ovarian cancer FIGO stages IIb–IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin

Open-label, multicenter, phase Ib, dose-escalation study of oral lapatinib (L) in combination with docetaxel (D) and trastuzumab (T) in untreated HER2-overexpressing (HER+) metastatic breast cancer (MBC)

Isolation and culture of ovarian tumour cells, cytological and cell survival evaluation

Updated efficacy and safety assessment of first-line therapy with lapatinib, trastuzumab, and paclitaxel in HER2+ metastatic breast cancer

TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer

BRCA1 and BRCA2 mutations in ovarian cancer: Covariation with specific cytogenetic features

The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers

Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms

Progesterone and estradiol stimulate release of epidermal growth factor/transforming growth factor alpha by ovarian tumours in vitro

Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum-taxane : Results from a multicenter phase I/II study

STEROID-HORMONE PRODUCTION AND RECEPTORS IN RELATION TO KI-67, P53, S-PHASE FRACTION AND PLOIDY IN EPITHELIAL OVARIAN-TUMORS

A Systematic Overview of Radiation Therapy Effects in Cervical Cancer (Cervix Uteri)

Suchergebnisse filtern